We also analysed TGFBI levels in cholagiocarcinoma, hepatocarcinoma, gastric carcinoma and pancreatic carcinoma patients for their association with clinical tumor stages, but no significant association was observed (data not shown). This evidence concerns the gene TGFBI and exocrine pancreatic carcinoma.